Jazz Pharmaceuticals plc buy The Goldman Sachs Group, Inc.
Start price
05.06.24
/
50%
€98.06
Target price
05.06.25
€155.23
Performance (%)
0.45%
Price
26.09.24
€98.50
Summary
This prediction is currently active. The BUY prediction by The_Goldman_Sachs_Gr for Jazz Pharmaceuticals plc is nearly unchanged. This prediction currently runs until 05.06.25. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Jazz Pharmaceuticals plc | -0.766% | -0.766% |
iShares Core DAX® | 3.523% | 3.763% |
iShares Nasdaq 100 | 1.026% | 2.380% |
iShares Nikkei 225® | -0.063% | 0.000% |
iShares S&P 500 | 0.557% | 2.222% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Jazz Pharmaceuticals plc diskutieren
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $169.00 price target on the stock.
Ratings data for JAZZ provided by MarketBeat
Stopped prediction by The_Goldman_Sachs_Gr for Jazz Pharmaceuticals plc
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€137.36
03.03.23
03.03.23
€199.47
03.03.24
03.03.24
-19.63%
04.03.24
04.03.24